[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. --------------------------------------------------------------- Sponsor Message [U.S. and China Locked in an all-out Resource War!](=) [Click here for this urgent investment opportunity](=) --------------------------------------------------------------- November 28, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [GRAPHITE: "Essential for America's National Defense"](=) you know each EV battery contains up to 220 pounds of graphite and China controls more than 90% of the world's graphite trade? But now that the U.S. has classified it as "essential for America's National Defense"... one little-known company could become America's ONLY fully integrated graphite provider. [Discover Who's Poised to Benefit In The U.S. vs. China Energy War](=) = --------------------------------------------------------------- [GoHealth, GOCO]( Recent Analyst Action: Ben Hendrix, analyst at RBC Capital, reiterates coverage on [GoHealth (GOCO)](in the Financial sector with a Hold rating and a price target of $1.00 (1 week ago). - Recent Price: $9.3 - Average Analyst Price Target: $1.00 (-89.25%) - Market Cap: $201.26M [TipRanks.com](=) also reports that [GoHealth](currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $1.00. The target pricing ranges from a high forecast of $1.00 down to a low forecast of $1.00. [GoHealth (GOCO)](’s last closing price was $9.3 which would put the average price target at $1.00. Here are 3rd party ratings for [GOCO](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Sell, Bottom 20% (200 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Fed Exposed! Former government insider tells ALL Secret plan to destroy the markets?](=) [former government insider]( just went on LIVE camera and exposed the Federal Reserve for what it REALLY is… An institution created in secret designed to rob you of your savings, and destroy your wealth. And even though we all know these central bankers have blood on their hands (inflation, the Greenspan bubble, Ben Bernanke)… No one, and I mean NO ONE expected [this](. If what this insider says is correct, you may only have days to prepare. [Click here to see his shocking exposé.]( --------------------------------------------------------------- [Streamline Health Solutions, STRM]( Recent Analyst Action: Brooks O'Neil, analyst at Lake Street, reiterates coverage on [Streamline Health Solutions (STRM)](=)in the Technology sector with a Buy rating and a price target of $3.00 (1 week ago). - Recent Price: $2.04 - Average Analyst Price Target: $3.00 (47.06%) - Market Cap: $111.83M [TipRanks.com]() also reports that [Streamline Health Solutions](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $3.00. The target pricing ranges from a high forecast of $3.00 down to a low forecast of $3.00. [Streamline Health Solutions (STRM)]()’s last closing price was $2.04 which would put the average price target at $3.00. Here are 3rd party ratings for [STRM](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click here for chart >>](=) -------------------------------------------------------------------------- [Paratek Pharmaceuticals, PRTK]( Recent Analyst Action: Ed Arce, analyst at H.C. Wainwright, reiterates coverage on [Paratek Pharmaceuticals (PRTK)](in the Healthcare sector with a Buy rating and a price target of $20.00 (3 weeks ago). - Recent Price: $2.29 - Average Analyst Price Target: $25.00 (991.70%) - Market Cap: $125.54M [TipRanks.com]() also reports that [Paratek Pharmaceuticals](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $25.00. The target pricing ranges from a high forecast of $30.00 down to a low forecast of $20.00. [Paratek Pharmaceuticals (PRTK)]()’s last closing price was $2.29 which would put the average price target at $25.00. Here are 3rd party ratings for [PRTK](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 22% (56 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [These 2 Dividend Stocks Pay Every Week]( you still looking for consistent income in this near-zero interest rate environment? There is a better way. I just revealed the Holy Grail of dividend stocks - a safe, reliable and consistent stock that [pays dividends EVERY single week](- 52 times a year. It's simple: Buy the stock this Monday and you'll get your first dividend payout in your bank account this Thursday....and then every Thursday after for as long as you own the stock! [Tap here to reveal the name of this stock for FREE.]( = --------------------------------------------------------------- [BioVie, BIVI]( Recent Analyst Action: Constantine Davides, analyst at EF Hutton, reiterates coverage on [BioVie (BIVI)](in the Healthcare sector with a Buy rating and a price target of $8.00 (2 months ago). - Recent Price: $6.77 - Average Analyst Price Target: $10.00 (47.71%) - Market Cap: $201.82M [TipRanks.com](=) also reports that [BioVie](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.00. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $8.00. [BioVie (BIVI)](’s last closing price was $6.77 which would put the average price target at $10.00. Here are 3rd party ratings for [BIVI](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 32% (80 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Zevia PBC, ZVIA](=) Recent Analyst Action: Andrew Strelzik, analyst at BMO Capital, reiterates coverage on [Zevia PBC (ZVIA)]()in the Consumer Goods sector with a Buy rating and a price target of $8.00 (2 weeks ago). - Recent Price: $4.09 - Average Analyst Price Target: $5.80 (41.81%) - Market Cap: $265.86M [TipRanks.com]( also reports that [Zevia PBC](=)currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $5.80. The target pricing ranges from a high forecast of $8.00 down to a low forecast of $3.50. [Zevia PBC (ZVIA)]()’s last closing price was $4.09 which would put the average price target at $5.80. Here are 3rd party ratings for [ZVIA](=): - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Buy, Bottom 43% (144 out of 251) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Biggest "Missing Ingredient" in the $7 Trillion EV Market](=) =China has owned the graphite market for decades. But the U.S. just added graphite to a list of super-critical minerals... "essential for America's National Defense." Perfect timing for a "made in America" graphite company looking to mine, manufacture, and recycle graphite for the booming electric car market. [Don't Miss Your Opportunity to Benefit from This Breaking News](=) --------------------------------------------------------------- [Ocuphire Pharma, OCUP]( Recent Analyst Action: Sean Kim, analyst at JonesTrading, reiterates coverage on [Ocuphire Pharma (OCUP)](=)in the Healthcare sector with a Buy rating and a price target of $16.00 (5 days ago). - Recent Price: $3.15 - Average Analyst Price Target: $21.75 (590.48%) - Market Cap: $64.69M [TipRanks.com]() also reports that [Ocuphire Pharma](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $21.75. The target pricing ranges from a high forecast of $26.00 down to a low forecast of $16.00. [Ocuphire Pharma (OCUP)]()’s last closing price was $3.15 which would put the average price target at $21.75. Here are 3rd party ratings for [OCUP](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 22% (56 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Safe-T Group, SFET]( Recent Analyst Action: Jason Kolbert, analyst at Dawson James, reiterates coverage on [Safe-T Group (SFET)](in the Technology sector with a Buy rating and a price target of $6.00 (2 months ago). - Recent Price: $3.3 - Average Analyst Price Target: $6.00 (81.82%) - Market Cap: $10.36M [TipRanks.com](=) also reports that [Safe-T Group](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $6.00. The target pricing ranges from a high forecast of $6.00 down to a low forecast of $6.00. [Safe-T Group (SFET)](’s last closing price was $3.3 which would put the average price target at $6.00. Here are 3rd party ratings for [SFET](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 24% (60 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Humble Mineral at the Heart of the EV Revolution (Not Lithium)]( =You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite - more than lithium, copper or aluminum! [Get the Full Story On This New American Graphite Opportunity](=) --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, The Editor, MarketSectorDaily.com [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( MarketSectorDaily.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane Mooresville, North Carolina 28115 United States (877) 411-9808